Ofev and Asthenopia - a phase IV clinical study of FDA data
Asthenopia is reported only by a few people who take Ofev.
The phase IV clinical study analyzes which people take Ofev and have Asthenopia. It is created by eHealthMe based on reports of 17,071 people who have side effects while taking Ofev from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
17,071 people reported to have side effects when taking Ofev.
Among them, 3 people (0.02%) have Asthenopia.
What is Ofev?
Ofev has active ingredients of nintedanib esylate. eHealthMe is studying from 17,096 Ofev users for its effectiveness, alternative drugs and more.
What is Asthenopia?
Asthenopia (eyestrain-tiredness of the eyes caused by prolonged close work by a person with an uncorrected vision problem) is found to be associated with 934 drugs and 562 conditions by eHealthMe.
Number of Ofev and Asthenopia reports submitted per year:
Gender of people who have Asthenopia when taking Ofev *:
- female: 33.33 %
- male: 66.67 %
Age of people who have Asthenopia when taking Ofev *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 33.33 %
- 60+: 66.67 %
Common drugs people take besides Ofev *:
- Tyvaso: 1 person, 33.33%
- Tamsulosin: 1 person, 33.33%
- Lotemax: 1 person, 33.33%
- Clopidogrel: 1 person, 33.33%
- Azelastine: 1 person, 33.33%
Common side effects people have besides Asthenopia *:
- Hoarseness Or Changing Voice: 2 people, 66.67%
- Vision Blurred: 2 people, 66.67%
- Cough: 2 people, 66.67%
- Productive Cough: 2 people, 66.67%
- Sinus Congestion (blockage of sinus): 2 people, 66.67%
- Dry Mouth: 1 person, 33.33%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 1 person, 33.33%
- Fatigue (feeling of tiredness): 1 person, 33.33%
- Fall: 1 person, 33.33%
- Eye Swelling: 1 person, 33.33%
Common conditions people have *:
- Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 66.67%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 33.33%
* Approximation only. Some reports may have incomplete information.
Do you take Ofev and have Asthenopia?Check whether Asthenopia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Asthenopia and when was it recovered:
Expand to all the drugs that have ingredients of nintedanib esylate:
Alternative drugs to, pros and cons of Ofev:
- Ofev (17,096 reports)
Common Ofev side effects:
Browse all side effects of Ofev:a b c d e f g h i j k l m n o p q r s t u v w x y z
Asthenopia treatments and more:
- Asthenopia (5,084 reports)
COVID vaccines that are related to Asthenopia:
- Asthenopia in Moderna COVID Vaccine
- Asthenopia in Pfizer BioNTech Covid Vaccine
- Asthenopia in Johnson and Johnson Covid Vaccine
Common drugs associated with Asthenopia:
- Aspirin: 130 reports
- Botox: 117 reports
- Enbrel: 109 reports
- Gilenya: 151 reports
- Metformin: 108 reports
- Prednisone: 141 reports
- Restasis: 158 reports
- Vitamin d: 109 reports
All the drugs that are associated with Asthenopia:
- Asthenopia (934 drugs)
Common conditions associated with Asthenopia:
All the conditions that are associated with Asthenopia:
- Asthenopia (562 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on nintedanib esylate (the active ingredients of Ofev) and Ofev (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Nolvadex and Metastasis - 9 seconds ago
- Zelboraf and Qvar drug interaction - 9 seconds ago
- Minocin and Uveitis - 34 seconds ago
- Advair Hfa and White Blood Cell Count Increased - 35 seconds ago
- Reclast vs. Alendronate Sodium - 53 seconds ago
- Tysabri and Thermohyperaesthesia - a minute ago
- Baclofen and Hepatic Steatosis - a minute ago
- Spironolactone and Fluid Overload - a minute ago
- Dopamine Hydrochloride vs. Akineton - a minute ago
- Aptivus and Confusion - a minute ago